Explain why LV failure occur in aortic regurgitation and how it's different from LV failure of mitrap regurgitation

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive material from multiple authoritative textbooks. Let me compile the answer:

LV Failure in Aortic Regurgitation (AR) vs. Mitral Regurgitation (MR)

Both AR and MR impose a volume overload on the LV, but the mechanisms of LV failure differ significantly due to fundamental differences in loading conditions, compensatory geometry, and the route of regurgitation.

Shared Foundation: Volume Overload

In both lesions, the LV must pump the normal forward stroke volume plus a regurgitant volume, stretching sarcomeres toward maximum length and activating the Frank-Starling mechanism. The LV dilates (eccentric hypertrophy), increasing end-diastolic volume to maintain forward output.

How LV Failure Develops in AR

The Key Distinction: Dual Overload (Volume + Pressure)

In AR, blood leaks back through the aortic valve during diastole — directly into the LV from the high-pressure aorta. This creates a uniquely hostile hemodynamic environment not seen in MR:
1. Increased Afterload (Systolic Pressure Overload)
  • The massive regurgitant stroke volume is ejected into the aorta every systole, causing a wide pulse pressure and elevated systolic aortic pressure
  • This systolic hypertension creates afterload excess, which does not generally occur in MR
  • The LV must therefore develop both eccentric hypertrophy (to handle volume) and concentric hypertrophy (to handle the pressure load)
  • This combination results in the largest end-diastolic volumes seen in any heart disease (Guyton: stroke volumes up to 250 mL, with up to 75% regurgitating back)
2. Impaired Coronary Perfusion
  • Coronary blood flow occurs predominantly in diastole
  • AR causes low aortic diastolic pressure (blood runs off back into the LV) while simultaneously raising LV end-diastolic pressure
  • This drastically reduces the coronary perfusion gradient (aortic diastolic pressure − LVEDP), causing subendocardial ischemia even without coronary artery disease
  • Increased LV mass from combined hypertrophy further raises oxygen demand while supply is reduced → angina and ischemic myocyte loss contribute to LV dysfunction
3. The Decompensation Cascade Progressive regurgitant load → further LV dilation → ↑ wall stress → LV hypertrophy eventually cannot keep pace → contractile dysfunction → ↓ EF, ↑ LVEDP → pulmonary congestion → CHF
From The Washington Manual:
"Steadily increasing regurgitant volume load → further ventricular dilation → ↑ wall stress → inability to continue further hypertrophy to ↓ afterload → contractile dysfunction → ↑ LVEDP → CHF symptoms (due both to congestion and ↓CO)" — The Washington Manual of Medical Therapeutics

How LV Failure Develops in MR

The Key Distinction: Low-Impedance Escape / Afterload-Sparing Mechanism

In MR, blood leaks backward through the mitral valve into the low-pressure left atrium during systole. This creates a very different hemodynamic profile:
1. Reduced Afterload (Initially)
  • The regurgitant pathway allows the LV to eject into the low-impedance LA, reducing LV end-systolic wall stress
  • This is why EF is typically supranormal (≥60–65%) in compensated MR — a "normal" EF actually masks underlying contractile dysfunction
  • There is no systolic hypertension, no significant concentric hypertrophy — geometry is purely eccentric
2. The Three Phases of MR (Goldman-Cecil):
PhaseMechanismLV Function
AcuteSudden volume overload; low-impedance pathway → ↑ EF, but forward SV ↓; LA pressure spikesEF normal or ↑, but CO ↓, pulmonary edema
Chronic compensatedEccentric hypertrophy, LA dilation; forward SV normalized; patient may be asymptomatic for yearsEF normal (≥60%), wall stress normalized
Chronic decompensatedContractile dysfunction; ↑ ESV; but favorable loading conditions (↑ preload + low afterload) mask the true EF drop; EF may still appear "normal" despite severe contractile damageEF may be 50–55% but contractility is severely impaired
3. The Hidden Trap of MR The afterload-sparing effect is the most clinically dangerous feature of MR: a patient can develop irreversible LV contractile dysfunction while the EF appears preserved or only mildly reduced. By the time EF drops below 60% or end-systolic dimension exceeds 4 cm, significant irreversible damage has already occurred. This is why MR surgery is recommended before the EF falls below 60%.

Head-to-Head Comparison

FeatureAortic RegurgitationMitral Regurgitation
Where blood leaksAorta → LV (diastole)LV → LA (systole)
Type of overloadVolume + Pressure (dual)Volume only
LV hypertrophy patternEccentric + concentric (combined)Purely eccentric
AfterloadIncreased (systolic HTN)Reduced or normal (low-impedance escape)
EF in decompensationFalls clearly (EF reflects true contractility)Remains deceptively preserved; EF of 55% = severe dysfunction
Coronary perfusionSeverely compromised (↓ diastolic Ao pressure, ↑ LVEDP)Relatively preserved
Angina without CADCommon — ischemia from ↓ perfusion gradientLess common
LV massLargest of any valvular diseaseLarge but less than AR
Path to failureAfterload excess + ischemia + contractile failureContractile dysfunction unmasked by loss of favorable loading
Acute presentationPulmonary edema + hypotension/shock (no time to compensate)Pulmonary edema (LA and pulmonary pressures spike acutely)

Key Conceptual Summary

The fundamental difference is the direction and timing of the regurgitant flow:
  • In MR, blood escapes into a low-pressure chamber during systole, which reduces LV afterload and allows a long compensated phase — but masks progressive contractile failure behind a falsely preserved EF.
  • In AR, blood returns from a high-pressure chamber during diastole, which adds both volume and pressure load, forces a combined hypertrophic response, and compromises coronary blood flow — ultimately causing LV failure through a combination of afterload excess, ischemia, and contractile dysfunction.
Sources: Goldman-Cecil Medicine, p. 690–694; Morgan & Mikhail's Clinical Anesthesiology, p. 772; The Washington Manual of Medical Therapeutics, p. 223–224; Guyton and Hall Textbook of Medical Physiology, p. 293
This is a shared conversation. Sign in to Orris to start your own chat.